Literature DB >> 26031973

Blood alanine aminotransferase levels >1,000 IU/l - causes and outcomes.

Zita Galvin1, Anna McDonough2, John Ryan2, Stephen Stewart3.   

Abstract

Standard medical education dictates that the vast majority of cases of an alanine aminotransferase (ALT) level >1,000 IU/l will be due to acute ischaemia, acute drug-induced liver injury (DILI) (usually paracetamol) or acute viral hepatitis. There are very few references in the literature to other potential causes of an ALT >1,000 IU/l nor to the prognosis ascribed to each aetiology. In this study, we have confirmed that the main causes of a dramatic ALT rise are ischaemic liver injury, DILI and viral hepatitis. Common bile duct stones and hepatitis E are two causes for which there needs to be a high index of suspicion as the necessary tests may not be in the clinician's first-line investigation panel. Failing to find a cause and determining that the cause was ischaemic both have poor prognostic implications. © Royal College of Physicians 2015. All rights reserved.

Entities:  

Keywords:  Alanine aminotransferase; acute hepatitis; aetiology; prognosis; transaminases

Mesh:

Substances:

Year:  2015        PMID: 26031973      PMCID: PMC4953107          DOI: 10.7861/clinmedicine.15-3-244

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  6 in total

Review 1.  Biomarkers of drug-induced liver injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  Adv Pharmacol       Date:  2019-03-06

2.  Enzymatic characterization of D-lactate dehydrogenase and application in alanine aminotransferase activity assay kit.

Authors:  Yi Sun; Guosheng Gao; Ting Cai
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  Microfluidic system for near-patient extraction and detection of miR-122 microRNA biomarker for drug-induced liver injury diagnostics.

Authors:  Maïwenn Kersaudy-Kerhoas; Antonio Liga; Appan Roychoudhury; Marilena Stamouli; Rhiannon Grant; Damaso Sanchez Carrera; Holger Schulze; Witold Mielczarek; Wilna Oosthuyzen; Juan F Quintana; Paul Dickinson; Amy H Buck; Nicholas R Leslie; Jurgen Haas; Till T Bachmann; James W Dear
Journal:  Biomicrofluidics       Date:  2022-04-18       Impact factor: 3.258

Review 4.  Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature.

Authors:  Philip Sarges; Joshua M Steinberg; James H Lewis
Journal:  Drug Saf       Date:  2016-09       Impact factor: 5.228

5.  Epidemiology and outcomes of marked elevations of alanine aminotransferase >1000 IU/L in an Australian cohort.

Authors:  Danny Con; Andrew Buckle; Amanda J Nicoll; John S Lubel
Journal:  JGH Open       Date:  2019-07-18

6.  MEK6 Overexpression Exacerbates Fat Accumulation and Inflammatory Cytokines in High-Fat Diet-Induced Obesity.

Authors:  Suyeon Lee; Myoungsook Lee
Journal:  Int J Mol Sci       Date:  2021-12-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.